Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Preparing to Give It (Part 1) |
|
Enduring |
|
$0.00 |
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Administration (Part 2) |
|
Enduring |
|
$0.00 |
Keeping up with the Chemos Series: Lenvatinib/Pembrolizumab - Follow up Monitoring Between Cycles (Part 3) |
|
Enduring |
|
$0.00 |
SGO Taskforce for Board Certification Support: Ovarian Cancer Resources - Preparing for the ABOG Oral Board Exam (Pt. 4) |
|
Enduring |
|
$0.00 |
SGO Taskforce for Board Certification Support: Highlighting Uterine Malignancies and GTD - Preparing for the ABOG Oral Exam (Pt. 5) |
|
Enduring |
|
$0.00 |
2023 Winter Meeting |
|
Enduring |
|
$0.00 |
SGO Journal Club On-Demand: Dear Healthcare Provider...the changing landscape of PARP inhibitor indications |
|
Enduring |
|
$0.00 |
Key Concepts of Enhanced Recovery After Surgery: ERAS – How Do We Do It? |
|
Enduring |
|
$0.00 |
SGO Taskforce for Board Certification Support: Cervical, Vulvar and Vaginal Cancer Resources - Preparing for the ABOG Oral Exam (Part 6) |
|
Enduring |
|
$0.00 |
Dermatology in Gyn Onc: Vulvar Lesions |
|
Enduring |
|
$0.00 |
Antineoplastic Therapy for Gynecologic Malignancies – 4th Edition |
|
Enduring |
|
$0.00 |
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Preparing to Give It (Part 1) |
|
Enduring |
|
$0.00 |
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Administration (Part 2) |
|
Enduring |
|
$0.00 |
Keeping up with the Chemos Series: Mirvetuximab Soravtansine - Follow up Monitoring Between Cycles (Part 3) |
|
Enduring |
|
$0.00 |
2022 Chemo Cards (Chemotherapy & Targeted Therapies Subcommittee) |
|
Enduring |
|
$0.00 |